Minchenko et al. indicated that overexpression of PFKFB4 in malignant tumors correlated with enhanced expression of HIF-1a, glucose transporter 1 (Glut1), and vascular endothelial growth factor (VEGF), which are known HIF-1-dependent genes [18, 42]. The gene discussed is SLC2A1; the disease is cancer.